دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Table of Contents
doi : 10.1016/S0190-9622(22)03012-2
Volume 88, Issue 1, January 2023, Pages A5-A6, A9-A10, A12-A16, A25, A30-A32, A41-A42
Information for Readers
doi : 10.1016/S0190-9622(22)03013-4
Volume 88, Issue 1, January 2023, Page A43
JAAD Case Reports Article List
doi : 10.1016/S0190-9622(22)03014-6
Volume 88, Issue 1, January 2023, Pages A45-A46, A48, A50
Journal Based CME Instructions and Information
doi : 10.1016/S0190-9622(22)03015-8
Volume 88, Issue 1, January 2023, Page A52
Dysplastic nevus part I: Historical perspective, classification, and epidemiology
Roman Drozdowski, BS, a Natalie Spaccarelli, MD, b Margot S. Peters, MD, c and Jane M. Grant-Kels, MD
doi : 10.1016/j.jaad.2022.04.068
Volume 88, Issue 1, January 2023, Pages 1-10
Answers to CME examination
doi : 10.1016/j.jaad.2022.11.024
Volume 88, Issue 1, January 2023, Page 12
Dysplastic nevus part II: Dysplastic nevi: Molecular/genetic profiles and management
Natalie Spaccarelli, MD, a Roman Drozdowski, BS, b Margot S. Peters, MD, c and Jane M. Grant-Kels, MD
doi : 10.1016/j.jaad.2022.05.071
Volume 88, Issue 1, January 2023, Pages 13-20
Answers to CME examination
doi : 10.1016/j.jaad.2022.11.026
Volume 88, Issue 1, January 2023, Page 22
Meeting the need for trusted information in a changing world
Dirk M. Elston, MD
doi : 10.1016/j.jaad.2022.07.034
Volume 88, Issue 1, January 2023, Page 23
This month in JAAD: January 2023
doi : 10.1016/j.jaad.2022.11.015
Volume 88, Issue 1, January 2023, Page 24
This Month in JAAD Case Reports: January 2023: Kratom hyperpigmentation
Brett Sloan, MD
doi : 10.1016/j.jaad.2022.10.048
Volume 88, Issue 1, January 2023, Page 25
This Month in JAAD International: January 2023: Toward a more inclusive vision of cosmetic surgery
Jonathan Kantor, MD, MSCE
doi : 10.1016/j.jaad.2022.11.008
Volume 88, Issue 1, January 2023, Page 26
Firm advances in sclerodermatous disorders
Warren R. Heymann, MD
doi : 10.1016/j.jaad.2022.11.021
Volume 88, Issue 1, January 2023, Pages 27-28
Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, placebo-controlled phase 3 POETYK PSO-1 trial
April W. Armstrong, MD, MPH, a Melinda Gooderham, MD, b Richard B. Warren, MD, c Kim A. Papp, MD, PhD, d Bruce Strober, MD, PhD, e Diamant Thac ̧i, MD, f Akimichi Morita, MD, PhD, g Jacek C. Szepietowski, MD, PhD, h Shinichi Imafuku, MD, i Elizabeth Colston, MD, PhD, j John Throup, PhD, j Sudeep Kundu, PhD, j Steve Schoenfeld, MD, j Misti Linaberry, MPH, j Subhashis Banerjee, MD, j and Andrew Blauvelt, MD, MBA
doi : 10.1016/j.jaad.2022.07.002
Volume 88, Issue 1, January 2023, Pages 29-39
Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, phase 3 Program fOr Evaluation of TYK2 inhibitor psoriasis second trial
Bruce Strober, MD, PhD, a Diamant Thac ̧i, MD, b Howard Sofen, MD, c Leon Kircik, MD, d Kenneth B. Gordon, MD, e Peter Foley, MD, f Phoebe Rich, MD, g Carle Paul, MD, PhD, h Jerry Bagel, MD, i Elizabeth Colston, MD, PhD, j John Throup, PhD, j Sudeep Kundu, PhD, j Chitra Sekaran, MD, j Misti Linaberry, MPH, j Subhashis Banerjee, MD, j and Kim A. Papp, MD, PhD k
doi : 10.1016/j.jaad.2022.08.061
Volume 88, Issue 1, January 2023, Pages 40-51
Sentinel lymph node biopsy in patients with T1a cutaneous malignant melanoma: A multicenter cohort study
Adrienne B. Shannon, MD, a Cimarron E. Sharon, MD, a Richard J. Straker III, MD, a Michael J. Carr, MD, MS, b,c Andrew J. Sinnamon, MD, MSCE, b Kita Bogatch, BA, d Alexandra Thaler, BA, a,e Nicholas Kelly, BA, a,e John T. Vetto, MD, f Graham Fowler, BS, f Danielle DePalo, MD, b Vernon K. Sondak, MD, b John T. Miura, MD, a Mark B. Faries, MD, g Edmund K. Bartlett, MD, d Jonathan S. Zager, MD, b and Giorgos C. Karakousis, MD
doi : 10.1016/j.jaad.2022.09.040
Volume 88, Issue 1, January 2023, Pages 52-59
Factors associated with suspected nonmelanoma skin cancers, dysplastic nevus, and cutaneous melanoma among first-time SpotMe screening program participants during 2009-2010
Derek Beaulieu, MD, a,b Hensin Tsao, MD, PhD, c Dominique S. Michaud, ScD, d Jean-Phillip Okhovat, MD, MPH, e Allan C. Halpern, MD, MS, f and Alan C. Geller, RN, MPH
doi : 10.1016/j.jaad.2018.12.010
Volume 88, Issue 1, January 2023, Pages 60-70
Predictors of time to relapse following ustekinumab withdrawal in patients with psoriasis who had responded to therapy: An 8-year multicenter study
Hsien-Yi Chiu, MD, PhD, a,b,c Rosaline Chung-yee Hui, MD, PhD, d,e,f Tsen-Fang Tsai, MD, a,b Yang-Ching Chen, PhD, g,h,i,j Nien-Feng Chang Liao, MD, k Po-Hua Chen, MD, a,b,l Po-Ju Lai, MD, m,n Ting-Shun Wang, MD, a,b,m,n and Yu-Huei Huang, MD
doi : 10.1016/j.jaad.2019.01.035
Volume 88, Issue 1, January 2023, Pages 71-78
Early ultrasound for diagnosis and treatment of vascular adverse events with hyaluronic acid fillers
Leonie W. Schelke, MD, a Peter Velthuis, MD, PhD, b Jonathan Kadouch, MD, b and Arthur Swift, MD
doi : 10.1016/j.jaad.2019.07.032
Volume 88, Issue 1, January 2023, Pages 79-85
Achieving consensus on patient-reported outcome measures in clinical practice for inflammatory skin disorders
Lourdes Perez-Chada, MD, MMSc, a Vanina L. Taliercio, MD, MS, b Alice B. Gottlieb, MD, PhD, c Marta Van Beek, MD, MPH, d Kristina Callis Duffin, MD, MSc, b Margo Reeder, MD, e Joseph F. Merola, MD, MMSc, f,g and Robert A. Swerlick, MD,
doi : 10.1016/j.jaad.2019.09.008
Volume 88, Issue 1, January 2023, Pages 86-93
Rifampin-moxifloxacin-metronidazole combination therapy for severe Hurley stage 1 hidradenitis suppurativa: prospective short-term trial and 1-year follow-up in 28 consecutive patients
Ma€ıa Delage, MD, a,b Jean-Philippe Jais, MD, PhD, c,d,e Thi Lam, MD, a,b Helene Guet-Revillet, MD, PhD, f Marie-Noelle Ungeheuer, MD, g Paul-Henri Consigny, MD, a,b Aude Nassif, MD, a,b and Olivier Join-Lambert, MD, PhD
doi : 10.1016/j.jaad.2020.01.007
Volume 88, Issue 1, January 2023, Pages 94-100
Measuring asymmetry in facial morphea via 3-dimensional stereophotogrammetry
Laila F. Abbas, MD, a Adrienne K. Joseph, MD, a Jennifer Day, MD, b Naomi A. Cole, MD, b Rami Hallac, PhD, b Christopher Derderian, MD, b and Heidi T. Jacobe, MD, MSCS
doi : 10.1016/j.jaad.2022.05.029
Volume 88, Issue 1, January 2023, Pages 101-108
Clinical outcomes of high-risk cutaneous squamous cell carcinomas treated with Mohs surgery alone: An analysis of local recurrence, regional nodal metastases, progression-free survival, and disease-specific death
Teo Soleymani, MD, a,b David G. Brodland, MD, a,c Julia Arzeno, MD, b Danny J. Sharon, MS, d and John A. Zitelli, MD
doi : 10.1016/j.jaad.2022.06.1169
Volume 88, Issue 1, January 2023, Pages 109-117
The incidence of cutaneous squamous cell carcinoma (cSCC) continues to increase, and it is now predicted that the number of deaths from cSCC will surpass that of melanoma within the next 5Â years. Although most cSCCs are successfully treated, there exists an important subset of high-risk tumors that have the highest propensity for local recurrence (LR), nodal metastasis (NM), and disease-specific death (DSD).
Mohs micrographic surgery and dermatopathology concordance: An analysis of 1421 Mohs cases over 17 years
Katarina Kesty, MD, MBA, a Omar P. Sangueza, MD, a Barry Leshin, MD, b,c and John G. Albertini, MD
doi : 10.1016/j.jaad.2017.11.055
Volume 88, Issue 1, January 2023, Pages 118-122
Insect repellents: An updated review for the clinician
Quoc-Bao D. Nguyen, MD, MBA, a Mai-Anh N. Vu, MD, b and Adelaide A. Hebert, MD
doi : 10.1016/j.jaad.2018.10.053
Volume 88, Issue 1, January 2023, Pages 123-130
Complementary and alternative medicine for alopecia areata: A systematic review
Elizabeth Tkachenko, BS, a,b Jean-Phillip Okhovat, MD, MPH, c Priya Manjaly, BA, b,d Kathie P. Huang, MD, b Maryanne M. Senna, MD, c and Arash Mostaghimi, MD, MPA, MPH
doi : 10.1016/j.jaad.2019.12.027
Volume 88, Issue 1, January 2023, Pages 131-143
Imaging technologies for presurgical margin assessment of basal cell carcinoma
Krishan Parashar, BS, a Angeli Eloise Torres, MD, b Wyatt Boothby-Shoemaker, BA, b,c Indermeet Kohli, PhD, b,d Jesse Veenstra, MD, PhD, b Victor Neel, MD, PhD, e and David M. Ozog, MD
doi : 10.1016/j.jaad.2021.11.010
Volume 88, Issue 1, January 2023, Pages 144-151
Sun protective behaviors among US racial and ethnic minorities with sun-sensitive skin
Costner McKenzie, BA, and Roopal V. Kundu, MD
doi : 10.1016/j.jaad.2019.06.1306
Volume 88, Issue 1, January 2023, Pages 152-153
Utility of laboratory testing in patients with female pattern hair loss
Jean-Phillip Okhovat, MD, MPH, a Dustin H. Marks, BS, a Athena Manatis-Lornell, BA, a Dina Hagigeorges, BS, a and Maryanne M. Senna, MD
doi : 10.1016/j.jaad.2019.07.015
Volume 88, Issue 1, January 2023, Pages 153-155
Skin cancer surveillance practices and attitudes among hairdressers: A cross-sectional study in Atlanta, Georgia
David C. Gibbs, BS, a,b Spencer Ng, MD, PhD, c Marissa L. H. Baranowski, BS, a,b Sampreet Reddy, MD, d Annelise Bederman, BS, MSc, b Marta B. Bean, BA, b Rachel Eisenstadt, MD, b and Suephy C. Chen, MD, MS
doi : 10.1016/j.jaad.2019.07.034
Volume 88, Issue 1, January 2023, Pages 155-158
Scalp verruca from barber clippers: An epidemiologic assessment of a common fomite
Jason R. Susong, MD, a,b Janelle Robertson, MD, c James C. Baldwin, PhD, d Kelly Riegleman, MD, e Andrew Daugherty, MD, f Hideaki L. Tanaka, MD, g Sarah Jelliffe, DO, h Sarah Kurszewski, b Caleb Sevcik, b and Taylor Pavone
doi : 10.1016/j.jaad.2020.04.064
Volume 88, Issue 1, January 2023, Pages 158-160
Trunk involvement and peau d'orange aspect are poor prognostic factors in eosinophilic fasciitis (Shulman disease): A multicenter retrospective study of 119 patients
Elina Zuelgaray, MD, a Sylvie Chevret, MD, PhD, b Marie Jachiet, MD, a Patrice Cacoub, MD, PhD, c Jean-Emmanuel Kahn, MD, PhD, d Matthieu Groh, MD, d Brigitte Granel, MD, PhD, e Manon Scafi, MD, e Lo€ık Geffray, MD, f Franc ̧ois Chasset, MD, PhD, g Marc Gatfosse, MD, h Arsene Mekinian, MD, PhD, h Bertrand Lioger, MD, i Alfred Mahr, MD, PhD, i Francis Gaches, MD, j Martin Michaud, MD, j Isabelle Ludot, MD, k Florence Cordoliani, MD, a Adele de Masson, MD, PhD, a Charles Cassius, MD, a Frederique Retornaz, MD, l Alexandra Audemard-Verger, MD, PhD, m Celine Lartigau-Roussin, MD, n Melanie Roriz, MD, o Benjamin Chaigne, MD, PhD, p Valerie Pallure, MD, q Isabelle Marie, MD, r Brice Castel, MD, s Valentine Loustau, MD, Laurent Chiche, MD, PhD, l Pierre-Edouard Gavand, MD, u Pascal Cathebras, MD, PhD, v Stephane Barete, MD, PhD, w Camille Frances, MD, PhD, g Emilie Brenaut, MD, x Yves Allenbach, MD, PhD, c Olivier Benveniste, MD, PhD, c Nicolas Noel, MD, y Geoffrey Urbanski, MD, z Olivier Hinschberger, MD, aa Didier Bessis, MD, PhD, bb Martine Bagot, MD, PhD, a Jean-David Bouaziz, MD, PhD, a and Damien Sene, MD, PhD cc Etude des Maladies Systemiques en Dermatologie, Societe Franc ̧aise de Dermatologie (Study Group of Systemic Diseases in Dermatology, French Society of Dermatology), Societe Nationale Franc ̧aise de Medecine Interne (French National Society of Internal Medicine), and Centre National de Reference des Syndromes Hypereosinophiliques
doi : 10.1016/j.jaad.2020.11.009
Volume 88, Issue 1, January 2023, Pages 160-163
Nasal reconstruction with one-stage dermal regeneration template and full-thickness skin graft: Long-term patient outcomes and complications
Inge J. Veldhuizen, MD, a Shenara Musthaq, BA, a Joseph J. Disa, MD, b Anthony Rossi, MD, a Kishwer S. Nehal, MD, a Babak J. Mehrara, MD, b and Erica H. Lee, MD
doi : 10.1016/j.jaad.2021.03.029
Volume 88, Issue 1, January 2023, Pages 163-164
Characteristics of the dermatologic cases on a popular crowdsourcing platform
Myles R. McCrary, MD, PhD, a Anika Wu, BS, a and Brian P. Pollack, MD, PhD
doi : 10.1016/j.jaad.2021.05.055
Volume 88, Issue 1, January 2023, Pages 164-165
Trichoscopy patterns of tinea capitis and their correlation with mycological culture results
Olıvia Mercilene Meneses, MD, a,b Aline Donati, MD, PhD, a Fabiana O. Silva, MD, a Marcelo J. Mimic ̧a, MD, PhD, c Carla J. Machado, MD, PhD, d and John Veasey, MD, PhD
doi : 10.1016/j.jaad.2021.12.010
Volume 88, Issue 1, January 2023, Pages 166-167
Asymmetric patterns of patient access to in-person and teledermatologic health care during the COVID-19 pandemic
Chirag Vasavda, BS, a,b Olive Tang, BA, b,c Shawn G. Kwatra, MD, b Byron K. Ho, MD, b and Anna L. Grossberg, MD
doi : 10.1016/j.jaad.2021.12.025
Volume 88, Issue 1, January 2023, Pages 167-169
The impact of achieving and maintaining near-complete or complete skin clearance on patient quality of life in moderate-to-severe psoriasis
Caitriona Ryan, MD, a,b Luis Puig, MD, PhD, c Carla Zema, PhD, d Elizabeth H. Z. Thompson, PhD, d Min Yang, MD, PhD, e Eric Wu, PhD, e Arielle Bensimon, PhD, e Xin Huang, PhD, d Avani D. Joshi, PhD, d and Boni Elewski, MD
doi : 10.1016/j.jaad.2021.12.032
Volume 88, Issue 1, January 2023, Pages 169-172
Patients with morphea with neurologic involvement: A cross-sectional study and review from the morphea in adults and children cohort
Laila F. Abbas, MD, a Adrienne K. Joseph, MD, a Jane L. Zhu, MD, a Darin Okuda, MD, b and Heidi T. Jacobe, MD, MSCS
doi : 10.1016/j.jaad.2021.12.049
Volume 88, Issue 1, January 2023, Pages 172-174
Characterization and treatment of prominent facial vasculature in the setting of frontal fibrosing alopecia
Lillian Sun, MD, a Shadi Mehrabi, MD, a Shilpi Khetarpal, MD, b and Melissa Piliang, MD
doi : 10.1016/j.jaad.2021.12.051
Volume 88, Issue 1, January 2023, Pages 174-176
Dermatologist awareness of scalp cooling for chemotherapy-induced alopecia
Lu Yin, MD, a Elizabeth J. Klein, MD, a Katerina Svigos, BS, a Taylor Novice, MD, b Daniel Gutierrez, MD, a Ruth Oratz, MD, c Mario E. Lacouture, MD, d Molly Powers, MD, b Maryanne Senna, MD, e Jerry Shapiro, MD, a and Kristen Lo Sicco, MD
doi : 10.1016/j.jaad.2022.03.009
Volume 88, Issue 1, January 2023, Pages 176-179
Disproportional signal of sexual dysfunction reports associated with finasteride use in young men with androgenetic alopecia: A pharmacovigilance analysis of VigiBase
David-Dan Nguyen, MPH, a,b Peter Herzog, MPH, a Eugene B. Cone, MD, a Muhieddine Labban, MD, a Kevin C. Zorn, MD, c Bilal Chughtai, MD, d Shehzad Basaria, MD, e Dean S. Elterman, MD, f Quoc-Dien Trinh, MD, a and Naeem Bhojani, MD, FRCSC
doi : 10.1016/j.jaad.2022.03.037
Volume 88, Issue 1, January 2023, Pages 179-181
A retrospective algorithmic application of a dermatologic complexity tool
Akash D. Patel, BS, a Melissa M. Sarver, BS, a Beiyu Liu, PhD, b Cynthia L. Green, PhD, b Matilda Nicholas, MD, PhD, a and Suephy C. Chen, MD, MS a
doi : 10.1016/j.jaad.2022.03.041
Volume 88, Issue 1, January 2023, Pages 181-183
Sexual orientation and gender identity inclusion in dermatology research: A 10-year analysis
Wyatt Boothby-Shoemaker, BA, a Matthew Mansh, MD, b Kara Sternhell-Blackwell, MD, c and Jon Klint Peebles, MD
doi : 10.1016/j.jaad.2022.03.043
Volume 88, Issue 1, January 2023, Pages 183-185
Increasing incidence of pediatric mycosis fungoides from 2000 to 2017: A national population-based study of the Surveillance, Epidemiology, and End Results database and Texas Cancer Registry
Joanne S. Jacob, BS, a and Raegan D. Hunt, MD, PhD
doi : 10.1016/j.jaad.2022.03.046
Volume 88, Issue 1, January 2023, Pages 185-187
Decreased progression to systemic lupus erythematosus in patients with cutaneous lupus erythematosus under European League Against Rheumatism/American College of Rheumatology criteria
Amanda M. Walker, BS, a Samantha M. Black, MD, a Frances Walocko, MD, a Xilong Li, PhD, b and Benjamin F. Chong, MD, MSCS
doi : 10.1016/j.jaad.2022.03.048
Volume 88, Issue 1, January 2023, Pages 187-190
Preliminary definition of cutaneous flare in dermatomyositis: A retrospective review
Joshua Dan, BA, Mohsen Afarideh, MD, MPH, Grant Sprow, BA, Emily Keyes, BA, DeAnna Diaz, MS, MBS, Thomas Vazquez, BS, Nilesh Kodali, BS, and Victoria P. Werth, MD
doi : 10.1016/j.jaad.2022.03.054
Volume 88, Issue 1, January 2023, Pages 190-191
A cohort study to determine factors associated with upstaging cutaneous squamous cell carcinoma during Mohs surgery
Theresa N. Canavan, MD, Arda B. Celen, BA, MSc, Nicholas J. Frazzette, MS, John A. Carucci, MD, PhD, Nicole Doudican, PhD, and Mary L. Stevenson, MD
doi : 10.1016/j.jaad.2022.03.055
Volume 88, Issue 1, January 2023, Pages 191-194
Association between state-specific reimbursement and Medicaid acceptance for Mohs micrographic surgery
Eric J. Beltrami, BS, a Jette Hooper, MD, b Vijay Kodumudi, BS, a Christian Gronbeck, MD, b and Hao Feng, MD, MHS
doi : 10.1016/j.jaad.2022.04.001
Volume 88, Issue 1, January 2023, Pages 194-196
Hyperhidrosis is associated with sleep disturbances, daytime tiredness, stress, and depression: A retrospective cohort study from the Danish Blood Donor Study
Mattias Henning, MSc, a Kristina Ibler, PhD, a Isabella Loft, MScEng, b Poul Jennum, DMSc, c Maria Didriksen, MSc, d Henrik Ullum, PhD, e Christian Erikstrup, PhD, f Kaspar Nielsen, PhD, g Mie Topholm Bruun, MSc, h Henrik Hjalgrim, DMSc, i,j,k Erik Sørensen, PhD, d Khoa Dinh, MSc, f Lise Wegner Thørner, PhD, d Gregor B. Jemec, DMSc, a and Ole Pedersen, PhD
doi : 10.1016/j.jaad.2022.03.063
Volume 88, Issue 1, January 2023, Pages 196-197
Vitiligo adverse events and associated medications as reported in the US Food and Drug Administration’s Adverse Event Reporting System from 2016 to 2021
Christine Learned, BA, Stephanie R. Cohen, MD, Sarah Alsukait, MBBS, Sandhya Deverapalli, MD, MBBS, and David Rosmarin, MD
doi : 10.1016/j.jaad.2022.04.010
Volume 88, Issue 1, January 2023, Pages 197-199
Factors associated with matching to a dermatology residency
Sonali Shah, BA,a Merit Gorgy, BS, a Sophia Arbuiso, BS, a Abigail Cline, MD, PhD, b Marian Russo, MD, b and Janet Moy, MD
doi : 10.1016/j.jaad.2022.04.014
Volume 88, Issue 1, January 2023, Pages 199-201
Prevalence and predictors of transportation barriers to health care among US adults with a history of skin cancer
David X. Zheng, BA, a Thomas B. Cwalina, MBA, a Kathleen M. Mulligan, BA, a Melissa A. Levoska, MD, a Jeffrey F. Scott, MD,b and Arash Mostaghimi, MD, MPA, MPH
doi : 10.1016/j.jaad.2022.04.023
Volume 88, Issue 1, January 2023, Pages 201-203
Treatment at high-volume facilities is associated with improved overall survival for patients with cutaneous B-cell lymphoma
Shayan Cheraghlou, MD, Nelson Ugwu, MD, and Michael Girardi, MD
doi : 10.1016/j.jaad.2022.04.032
Volume 88, Issue 1, January 2023, Pages 203-205
Allergens and marketing claims of the most popular baby moisturizers: A product analysis
Jonathan W. Rick, MD, a Austin Morgan, MD, a Devea R. De, BS, b Jennifer L. Hsiao, MD, c and Vivian Y. Shi, MD
doi : 10.1016/j.jaad.2022.04.034
Volume 88, Issue 1, January 2023, Pages 205-207
An analysis of internal and regional dermatology matches during the second year of the COVID-19 pandemic: A cross-sectional study
Travis S. Dowdle, BS, a Michael P. Ryan, MD, b Michelle B. Tarbox, MD, c and Richard F. Wagner, MD
doi : 10.1016/j.jaad.2022.04.036
Volume 88, Issue 1, January 2023, Pages 207-209
Greater rosacea severity correlates with greater adherence and improvement in a clinical study
Patrick O. Perche, BS, a Rohan Singh, BS, a Madison K. Cook, BS, a Katherine A. Kelly, BS, a Esther A. Balogh, MD, a Irma Richardson, MHA, a and Steven R. Feldman, MD, PhD
doi : 10.1016/j.jaad.2022.04.037
Volume 88, Issue 1, January 2023, Pages 209-210
Poorly differentiated eccrine carcinomas are associated with increased risk for poor outcomes
Neha Gupta, MPH, a,b Alexa Conomikes, BA, a Fadi Murad, MD, MPH, a and Emily S. Ruiz, MD, MPH
doi : 10.1016/j.jaad.2022.04.039
Volume 88, Issue 1, January 2023, Pages 210-212
Single-question parent-reported global atopic dermatitis severity: A valid instrument in children
Jonathan I. Silverberg, MD, PhD, MPH, a,b Stephanie M. Rangel, PhD, b Anjani Sheth, MD, b Alli Blumstein, MD, b and Amy S. Paller, MS, MD
doi : 10.1016/j.jaad.2022.04.040
Volume 88, Issue 1, January 2023, Pages 212-215
Clinicopathologic and molecular analyses of cutaneous leiomyosarcoma: A retrospective, multicenter study of 79 cases
vier Dereure, MD, PhD, a Pierre-Emmanuel Stoebner, MD, PhD, c Marie-Christine Picot, MD, PhD, d Marion Soler, MD, d Laurent Meunier, MD, PhD, a Nathalie Cardot-Leccia, MD, e Valerie Kubiniek, MD, f,g Ilaria Di Mauro, MSc, f,g Michael Delhorbe, BSc, f,g Jean-Philippe Lacour, MD, PhD, h Thierry Passeron, MD, PhD, h,i Florence Pedeutour, PharmD, PhD, f,g Henri Montaudie, MD, PhD, h,i and Berengere Dadone-Montaudie, MD, PhD f
doi : 10.1016/j.jaad.2022.03.066
Volume 88, Issue 1, January 2023, Pages 215-216
Annual health care utilization and cost of granuloma annulare in the United States, 2016 to 2019: A cross-sectional study
Ronald Berna, MD, a David J. Margolis, MD, PhD, a,b William Damsky, MD, PhD,c and John S. Barbieri, MD, MBA
doi : 10.1016/j.jaad.2022.04.041
Volume 88, Issue 1, January 2023, Pages 217-219
Classification of disease damage and activity in cutaneous lupus erythematosus: A cross-sectional analysis
Laila F. Abbas, MD, a Karabi Nandy, PhD, b and Benjamin F. Chong, MD, MSCS
doi : 10.1016/j.jaad.2022.04.045
Volume 88, Issue 1, January 2023, Pages 219-221
Inflammatory ocular comorbidities in alopecia areata: A retrospective cohort study of a single academic center
Akshitha Thatiparthi, BS, a Amylee Martin, BS, a Susie Suh, BA, a,b Katerina Yale, MD, a and Natasha Atanaskova Mesinkovska, MD, PhD
doi : 10.1016/j.jaad.2022.06.018
Volume 88, Issue 1, January 2023, Pages 221-223
Evaluation of chargemaster price transparency for dermatologic procedures: A national analysis
Kevin Yang, BS, a,b Lara Drake, BA, a,b Shilpa Ghatnekar, MD, MS, MBA, a William C. Lau, BA, b,c Adam Faletsky, MD, MBA, a Sheena Desai, MD, MBA, d and Vinod E. Nambudiri, MD, MBA
doi : 10.1016/j.jaad.2022.04.049
Volume 88, Issue 1, January 2023, Pages 223-226
Incidence and trends of cutaneous adnexal tumors in the United States in 2000-2018: A population-based study
David C. Gibbs, PhD, a Howa Yeung, MD, MSc, a,b,c and Travis W. Blalock, MD
doi : 10.1016/j.jaad.2022.04.052
Volume 88, Issue 1, January 2023, Pages 226-228
Gender and disparity in authorship: An analysis of dermatology randomized clinical trials
Jose W. Ricardo, MD, a Asghar Shah, b Yuqing Qiu, MS, c and Shari R. Lipner, MD, PhD
doi : 10.1016/j.jaad.2022.05.002
Volume 88, Issue 1, January 2023, Pages 228-231
Sunscreen compliance with American Academy of Dermatology recommendations: A 2022 update and cross-sectional study
Loren E. Hernandez, BSN, Noreen Mohsin, BSN, Fabio Frech, BSN, and Keyvan Nouri, MD, MBA
doi : 10.1016/j.jaad.2022.05.003
Volume 88, Issue 1, January 2023, Pages 231-232
Measuring improvement in psoriasis and dermatitis: The development of pruritus clinical quality measures
Stephanie C. Braxton, MPH, a Steven D. Daveluy, MD, FAAD, b Jason H. Raad, PhD, c Margo J. Reeder, MD, FAAD, d Milan J. Anadkat, MD, FAAD, e Kaylan L. Weese, MD, FAAD, f and Laura Vera, MSW, LSW
doi : 10.1016/j.jaad.2022.04.062
Volume 88, Issue 1, January 2023, Pages 233-234
Management of juvenile-onset systemic sclerosis with systemic immunosuppressive therapies: An evidence-based review
Abrahim Abduelmula, BScN, a Brian D. Rankin, PhD, b Nadia J. Luca, MD, c,d and Vimal H. Prajapati, MD
doi : 10.1016/j.jaad.2022.05.010
Volume 88, Issue 1, January 2023, Pages 234-236
Proposing a standardized assessment of COVID-19 vaccine-associated cutaneous reactions
Rhea Singh, BS, a,b Rowanne Ali, BS, a,c Sonya Prasad, BS, a,d Steven T. Chen, MD, MPH, MHPEd, a Kimberly Blumenthal, MD, MSc, e and Esther E. Freeman, MD, PhD
doi : 10.1016/j.jaad.2022.05.011
Volume 88, Issue 1, January 2023, Pages 237-241
Combination of acitretin and narrowband UV-B for the treatment of vitiligo: A new treatment modality with an impact on tissue E-cadherin expression
Shahira Ramadan, MD, a Ola Abu Zeid, MD, a Samia Esmat, MD, a Noha Adly Saleh, MSc, a Magda Assaf, MD, b,c and Rana Fathy Hilal, MD
doi : 10.1016/j.jaad.2022.05.012
Volume 88, Issue 1, January 2023, Pages 241-243
Real-world data on the clinical use of secukinumab in pediatric generalized pustular psoriasis: A 48-week retrospective study
Shi-Fan Ruan, MD, a Liang-Liang Zhang, MD, a Zhuo Liu, MD, a Ting-Ting Lin, MD, a Hai-Qing Wang, MD, a Qiu-Yun Xu, MD, a Niu Xiang, MD,Bo Cheng, PhD, a Tao Liu, MD, b Herena Y. Ha, PhD, c Ting Gong, PhD, d and Chao Ji, PhD a
doi : 10.1016/j.jaad.2022.04.064
Volume 88, Issue 1, January 2023, Pages 243-246
Evaluating patterns of co-occurrence between cutaneous and noncutaneous immune-related adverse events after immune checkpoint inhibitor therapy
Maria S. Asdourian, MPhil, a,b Nishi Shah, BS, b,c Ted V. Jacoby, BS, b,d Leah L. Thompson, MD, a,b Tracey Otto, MS, e Yevgeniy R. Semenov, MD, MA, a,b Kerry L. Reynolds, MD, a,f and Steven T. Chen, MD, MPH, MS-HPEd
doi : 10.1016/j.jaad.2022.05.015
Volume 88, Issue 1, January 2023, Pages 246-249
Timing of sentinel lymph node biopsy in cutaneous squamous cell carcinoma
Trent D. Walker, BS, a Austin Cusick, DO, b Kathryn T. Shahwan, MD,c,d and David R. Carr, MD, MPH
doi : 10.1016/j.jaad.2022.05.016
Volume 88, Issue 1, January 2023, Pages 249-251
Patterns of recurrence and prognosis in pathologic stage I and II Merkel cell carcinoma: A multicenter, retrospective cohort analysis
Andrew D. Tieniber, MD, a Adrienne B. Shannon, MD, a Michael J. Carr, MD, b James Sun, MD, b Karenia Landa, MD, c Kirsten M. Baecher, MD, d Kevin Lynch, MD, e Harrison G. Bartels, MD, f Robyn Panchaud, BS, b Michael C. Lowe, MD, d Craig L. Slingluff, MD, e Mark J. Jameson, MD, f Kenneth Y. Tsai, MD, b Mark B. Faries, MD, g Georgia M. Beasley, MD, c Vernon K. Sondak, MD, b Giorgos C. Karakousis, MD, h Jonathan S. Zager, MD, b,i and John T. Miura, MD
doi : 10.1016/j.jaad.2022.05.019
Volume 88, Issue 1, January 2023, Pages 251-253
Modified Score of Toxic Epidermal Necrolysis to predict toxic epidermal necrolysis mortality
Zahra Haghani Dogahe, MD, a Anahita Ghorbani, MD, a,b Shahin Hallaj, MD,a,c and Mohammadreza Mobayen, MD
doi : 10.1016/j.jaad.2022.05.020
Volume 88, Issue 1, January 2023, Pages 254-255
Dupilumab-associated head and neck dermatitis resolves temporarily with itraconazole therapy and rapidly with transition to upadacitinib, with Malassezia-specific immunoglobulin E levels mirroring clinical response
Emily Kozera, MD, MPH, MBeth, a,b Akshay Flora, MD, MMed, a,b,c Thomas Stewart, MBBS, MMed, MS, a Kyra Gill, c Jennifer Xu, c Mae Anne De La Vega, BSN, RN, a and John W. Frew, MBBS, MMed, MS, PhD
doi : 10.1016/j.jaad.2022.05.021
Volume 88, Issue 1, January 2023, Pages 255-257
Automated pharmacy substitution for medications not covered by Medicaid: A model for reducing the burden of prior authorizations in dermatology
Deega Omar, MPH, a,b Jessica B. Brown-Korsah, BS, a,c Susan C. Taylor, MD, a and Nicholas Mollanazar, MD, MBA a
doi : 10.1016/j.jaad.2022.09.039
Volume 88, Issue 1, January 2023, Pages 258-260
A retrospective analysis of hydrophilic polymer and potassium ferrate as a well-tolerated alternative to suture for 4-mm punch biopsies in hospitalized patients
Victor Wu, BA, a Jaimie Lin, BS, a Jawaher Assed, BS, a Emily Altman, MD, b and John R. Durkin, MD
doi : 10.1016/j.jaad.2022.08.007
Volume 88, Issue 1, January 2023, Pages 261-262
Scar revision coverage via crime victim assistance and compensation services
Kathryn Bentivegna, MPH, a and Jane M. Grant Kels, MD
doi : 10.1016/j.jaad.2022.10.028
Volume 88, Issue 1, January 2023, Pages 263-264
Anchoring bias and heuristics can perpetuate disparities in dermatology
Justin L. Jia, MS, a and Jenna C. Lester, MD
doi : 10.1016/j.jaad.2022.05.059
Volume 88, Issue 1, January 2023, Pages 265-266
Ethics of documenting patient’s race and ethnicity in dermatology clinical notes and presentations
Mehdi Farshchian, MD, PhD, a and Jane M. Grant- Kels, MD
doi : 10.1016/j.jaad.2022.02.020
Volume 88, Issue 1, January 2023, Page 267
JAAD Game Changers∗: Cellulitis Recurrence Score: A tool for predicting recurrence of lower limb cellulitis
Eliot N. Mostow, MD
doi : 10.1016/j.jaad.2019.07.089
Volume 88, Issue 1, January 2023, Page 268
JAAD Game Changers∗: A systematic review of the safety and efficacy of systemic corticosteroids in atopic dermatitis
Eliot Mostow, MD
doi : 10.1016/j.jaad.2019.07.091
Volume 88, Issue 1, January 2023, Page 269
Beyond JAAD January 2023
Andrew Bronin, MD
doi : 10.1016/j.jaad.2022.09.046
Volume 88, Issue 1, January 2023, Pages e1-e4
Using the blue screen of a smartphone as an alternative to Wood’s lamp for examination of vitiligo
Sandip Agrawal, MD, Aseem Sharma, MD, Rachita Dhurat, MD, and Kiran Chahal, MD
doi : 10.1016/j.jaad.2019.04.041
Volume 88, Issue 1, January 2023, Pages e5-e6
A potassium hydroxide fountain pen for precise application over molluscum contagiosum lesions
Sandip Agrawal, MD, Aseem Sharma, MD, Maryam Motiwala, MD, and Rachita Dhurat, MD Mumbai, India
doi : 10.1016/j.jaad.2019.05.058
Volume 88, Issue 1, January 2023, Pages e7-e8
A novel technique to safely maximize botulinum toxin extraction from 50-unit vials
Isadore S. Tarantino, MD, a Brett C. Neill, MD, a Melanie N. Wolf, BS, b Anand Rajpara, MD, a and Daniel J. Aires, MD, JD a
doi : 10.1016/j.jaad.2018.10.080
Volume 88, Issue 1, January 2023, Pages e9-e10
Treating port wine stain birthmarks by using dynamic optical coherence tomography–guided settings
Mitalee P. Christman, MD, a,b Hao Feng, MD, MHS, a,b Jon Holmes, MA, FInstP, c and Roy G. Geronemus, MD
doi : 10.1016/j.jaad.2019.08.028
Volume 88, Issue 1, January 2023, Pages e11-e13
Reply to: “Comment on ‘Risk of skin cancer in HIV-infected patients: A Danish nationwide cohort study’�
Silje H. Omland, MD, PhD, and Lars H. Omland, MD, PhD
doi : 10.1016/j.jaad.2018.08.045
Volume 88, Issue 1, January 2023, Page e15
Comment on “Risk of skin cancer in HIV-infected patients: A Danish nationwide cohort study�
Dustin H. Marks, BS, a and Matthew D. Mansh, MD
doi : 10.1016/j.jaad.2018.07.067
Volume 88, Issue 1, January 2023, Pages e17-e18
Reply to: “Comment on ‘Occurrence of vismodegib-induced cramps (muscular spasms) in the treatment of basal cell carcinoma: A prospective study in 30 patients'�
Matthew S. Dinehart, MD, a Stacy McMurray, MD, b Scott Dinehart, MD, c and Mark Lebwohl, MD
doi : 10.1016/j.jaad.2018.07.069
Volume 88, Issue 1, January 2023, Page e19
Comment on “Trends in phototherapy utilization among Medicare beneficiaries in the United States, 2000 to 2015�
Franc ̧ois Aubin, MD, PhD, Eve Puzenat, MD, Fabien Pelletier, MD, PhD, Charlee Nardin, MD, and Florence Castelain, MD
doi : 10.1016/j.jaad.2018.10.071
Volume 88, Issue 1, January 2023, Pages e21-e22
Reply
Sally Tan, MD, Elizabeth Buzney, MD, and Arash Mostaghimi, MD, MPA, MPH
doi : 10.1016/j.jaad.2018.12.025
Volume 88, Issue 1, January 2023, Pages e23-e24
Re: “Time to reconsider the role of sentinel lymph node biopsy in melanoma�
Mark B. Faries, MD, a Alistair J. Cochran, MD, MBChB, b and John F. Thompson, MD
doi : 10.1016/j.jaad.2019.03.064
Volume 88, Issue 1, January 2023, Pages e25-e26
Letter to the editor
Samuel Zagarella, MD, a Michael Bigby, MD, b,c Michael Sladden, MD, d and Catalin Popescu, MD
doi : 10.1016/j.jaad.2019.03.061
Volume 88, Issue 1, January 2023, Page e27
Comment on “Basal cell carcinoma: Contemporary approaches to diagnosis, treatment, and prevention�
Anirudh Sethi, PhD, Meagan Vogt, PhD, Jason Brocato, PhD, Lindsay Habeeb, MD, and Nicholas Squittieri, MD
doi : 10.1016/j.jaad.2019.07.095
Volume 88, Issue 1, January 2023, Pages e29-e30
Rifampin and clindamycin are safe long-term: Response to “North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations Part II: Topical, intralesional, and systemic medical management�
Joerg Albrecht, MD, PhD, a,b and Michael Bigby, MD
doi : 10.1016/j.jaad.2019.08.088
Volume 88, Issue 1, January 2023, Page e31
Reply to “Rifampin and clindamycin are safe long-term�
Christopher Sayed, MD, a and Ali Alikhan A, MD
doi : 10.1016/j.jaad.2019.09.048
Volume 88, Issue 1, January 2023, Page e33
Panoramic dermoscopy
Leonardo Spagnol Abraham, MD, MSc, a Sofia Sales Martins, MD, b Rodrigo Pirmez, MD, c and Bruna Duque-Estrada, MD
doi : 10.1016/j.jaad.2019.09.082
Volume 88, Issue 1, January 2023, Page e35
Letter in Reply: Promoting accurate public health messages about electronic cigarettes: E-cigs contain carcinogens
Kathryn Bentivegna, MPH, a Maciej L. Goniewicz, PharmD, PhD, b and Reid A. Waldman, MD
doi : 10.1016/j.jaad.2019.11.054
Volume 88, Issue 1, January 2023, Page e37
Reply to: “Promoting accurate public health messages about electronic cigarettes: E-cigs contain carcinogens�
Michael J. Visconti, BSc, a and Kurt A. Ashack, MD
doi : 10.1016/j.jaad.2019.11.053
Volume 88, Issue 1, January 2023, Page e39
Response to “Transparent grid system as a novel tool to prevent wrong-site skin surgery on the back�
David Veitch, MBChB, BSc, MRCP (Derm), Aaron Wernham, MBChB (Hons), MRCP (Derm), and Sandeep Varma, MBBCh, BMedSci (Hons), MRCP, FRCP
doi : 10.1016/j.jaad.2019.12.051
Volume 88, Issue 1, January 2023, Pages e41-e42
Reply to “Response to: ‘Transparent grid system as a novel tool to prevent wrong-site skin surgery on the back’�
Vikram Rajput, MBBS, BMedSci, FRACGP
doi : 10.1016/j.jaad.2019.12.052
Volume 88, Issue 1, January 2023, Page e43
Comment on “Skin disease of the breast and nipple�
Daniel Gutierrez, MD, Alexa B. Steuer, MPH, Miriam K. Pomeranz, MD, and Alisa N. Femia, MD
doi : 10.1016/j.jaad.2020.01.029
Volume 88, Issue 1, January 2023, Pages e45-e46
Comment on skin biopsies for diagnosing intravascular lymphoma: A retrospective study of diagnostic accuracy
Naoko Enzan, MD, a Akihiro Kitadate, MD, PhD, b and Michihiro Kono, MD, PhD
doi : 10.1016/j.jaad.2021.03.127
Volume 88, Issue 1, January 2023, Pages e47-e48
Reply to Letter to the Editor in response to “Skin Biopsy in the Diagnosis of Intravascular Lymphoma: A Retrospective Diagnostic Accuracy Study�
Joe K. Tung, MD, MBA, a Daniel Rozenbaum, MD, b Renajd Rrapi, BA, c Sidharth Chand, BA, c Yun Xue, MD, c Mai P. Hoang, MD, d and Daniela Kroshinsky, MD, MPH
doi : 10.1016/j.jaad.2021.07.024
Volume 88, Issue 1, January 2023, Page e49
Response to Chu et al’s “Developing and implementing approaches to limit antimicrobial resistance�
Fiorinda F. Muhaj, MD, a and Stephen K. Tyring, MD, PhD
doi : 10.1016/j.jaad.2022.07.052
Volume 88, Issue 1, January 2023, Pages e51-e52
Diagnostic considerations in suspected cases of monkeypox
Urmi Khanna, MD, Yana Kost, BS, and Benedict Wu, DO, PhD
doi : 10.1016/j.jaad.2022.09.034
Volume 88, Issue 1, January 2023, Pages e53-e55
Biologic treatment for psoriasis is unlikely to facilitate psoriatic arthritis development
Miao Chen, PhD, and Sheng-Ming Dai, MD, PhD
doi : 10.1016/j.jaad.2022.09.044
Volume 88, Issue 1, January 2023, Pages e57-e58
Chemotherapy-associated paronychia: Do not forget the children
Paola Borgia, MD, a Gianluca Piccolo, MD, a,b Maria Cristina Diana, MD, c and Gianmaria Viglizzo, MD
doi : 10.1016/j.jaad.2022.09.045
Volume 88, Issue 1, January 2023, Page e59
Crucial conceptual concepts in the evaluation and management of advanced basal cell carcinoma
Philip R. Cohen, MD, a,b and Razelle Kurzrock, MD
doi : 10.1016/j.jaad.2022.07.066
Volume 88, Issue 1, January 2023, Pages e61-e62
Advanced basal cell carcinoma: What dermatologists need to know about treatment
Farhaan Hafeez, MD, a Melissa Wilson, MD, PhD, b Stephen C. Senft, MD, a Ryan P. Johnson, MD, a Alan Westheim, MD, a Nadia Abidi, MD, a and Andrew C. Krakowski, MD
doi : 10.1016/j.jaad.2022.10.013
Volume 88, Issue 1, January 2023, Page e63
Response to the article by Narla et al “Management of inadequate response and adverse effects to dupilumab in atopic dermatitis�
Niccolo Gori, MD, a,b Andrea Chiricozzi, MD, a,b and Ketty Peris, MD
doi : 10.1016/j.jaad.2022.09.055
Volume 88, Issue 1, January 2023, Pages e65-e66
Remembering Robert Willan: How one man forever changed the way we approach skin diseases
Peter A. Young, MPAS
doi : 10.1016/j.jaad.2022.09.052
Volume 88, Issue 1, January 2023, Pages e67-e69
JANUARY 2023 IOTADERMA (#347)
Robert I. Rudolph, MD
doi : 10.1016/j.jaad.2022.06.004
Volume 88, Issue 1, January 2023, Page e71
DECEMBER 2022 iotaderma (#346)
Robert I. Rudolph, MD
doi : 10.1016/j.jaad.2022.05.004
Volume 88, Issue 1, January 2023, Page e71
